Head and neck cancer (HNC) is malignant, genetically complex and difficult to treat and is
the sixth most frequent cancer, with tobacco, alcohol and human papillomavirus being major …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer type,
has often an aggressive course and is poorly responsive to current therapeutic approaches …

Opinion Statement Epidermal growth factor receptor (EGFR) is commonly overexpressed in
many head and neck squamous cell carcinomas (HNSCC). With the success of EGFR …

Background Squamous cell carcinoma (SCC) is a relatively common and heterogenous
malignancy of different organs, such as the skin, esophagus, and lungs. Although most …

Oesophageal squamous cell carcinoma (ESCC) is a kind of malignant tumour with high
invasiveness and a poor prognosis. Immunotherapy, especially immune checkpoint …

Introduction Demographics are important prognostic factors in malignant diseases. A
nationwide analysis concerning the prognostic impact of demographics in head and neck …

Objective To evaluate the efficacy and safety of combination immunochemotherapy
regimens for the treatment of recurrent or metastatic head and neck squamous cell …

Head and neck cancer is a broad family of diseases, most of which are of squamous cell
origin, affecting the epithelial mucosa lining the upper aerodigestive tract. They often recur …

Head and neck squamous cell carcinoma (HNSCC) is among the common tumors
associated with high mortality. The aim of our meta‐analysis was to determine how …

Importance Squamous cell carcinoma of the head and neck (HNSCC) is prevalent globally
and in the US. Management, particularly after disease recurrence, can be challenging, and …